Showing results (1-10 of 164) with videos related to
Sort By:
Pageof 17
Current Opinion in Immunology|May 15, 2010
New adjuvants for human vaccinesM Lamine Mbow, Ennio De Gregorio, Nicholas M Valiante, et al.Frontiers in Immunology|August 6, 2013
Vaccine adjuvants: mode of actionEnnio De Gregorio, Elena Caproni, Jeffrey B UlmerTrends in Biotechnology|July 31, 2004
What is disrupting IFN-alpha's antiviral activity?M Lamine Mbow, Robert T SariskyDrug News & Perspectives|May 26, 2005
Modulating toll-like receptor signalling as a novel antiinfective approachM Lamine Mbow, Robert T SariskyMicrobial Biotechnology|September 2, 2011
Vaccines for the future: learning from human immunologyEnnio De Gregorio, Rino RappuoliNature Reviews. Immunology|June 14, 2014
From empiricism to rational design: a personal perspective of the evolution of vaccine developmentEnnio De Gregorio, Rino RappuoliPlos One|August 16, 2016
Self-Amplifying mRNA Vaccines Expressing Multiple Conserved Influenza Antigens Confer Protection against Homologous and Heterosubtypic Viral ChallengeDiletta Magini, Cinzia Giovani, Simona Mangiavacchi, et al.Drug Discovery Today|June 11, 2009
The path to a successful vaccine adjuvant--'the long and winding road'Derek T O'Hagan, Ennio De GregorioBlood|April 14, 2011
Small molecule Toll-like receptor 7 agonists localize to the MHC class II loading compartment of human plasmacytoid dendritic cellsCarla Russo, Ivan Cornella-Taracido, Luisa Galli-Stampino, et al.Pageof 17